Incyte (INCY) Change in Cash (2010 - 2026)
Incyte's (INCY) quarterly Change in Cash came in at $521.2 million in Q2 2026, up 3782.33% YoY from $13.4 million in Q2 2025, and up 43.48% on a QoQ basis from $363.3 million in Q1 2026.
Analysis
Incyte (INCY) Change in Cash (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of Change in Cash data on file, last reported at $521.2 million in Q2 2026.
- Quarterly Change in Cash rose 3782.33% year-over-year to $521.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 billion (up 109.46% YoY) and the FY2025 annual result came in at $1.4 billion, up 192.43% from the prior year.
- Change in Cash improved to $521.2 million in Q2 2026, from $363.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $642.8 million in Q4 2025 to a low of -$2.4 billion in Q2 2024.
- A 5-year average of $106.9 million and a median of $254.6 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash plunged 860.76% — and 2026, when it surged 3782.33%.
- Tracing INCY's Change in Cash over 5 years: stood at $260.9 million in 2022, then slumped by 105.26% to -$13.7 million in 2023, then surged by 2894.73% to $383.6 million in 2024, then jumped by 67.57% to $642.8 million in 2025, then retreated by 18.91% to $521.2 million in 2026.
- The last three Change in Cash figures came in at $521.2 million (Q2 2026), $363.3 million (Q1 2026), and $642.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 521.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 521.24 Mn |
| Mar 31, 2026 | 363.28 Mn |
| Dec 31, 2025 | 642.82 Mn |
| Sep 30, 2025 | 500.04 Mn |
| Jun 30, 2025 | 13.43 Mn |
| Mar 31, 2025 | 253.94 Mn |
| Dec 31, 2024 | 383.61 Mn |
| Sep 30, 2024 | 316.92 Mn |
| Jun 30, 2024 | -2.36 Bn |
| Mar 31, 2024 | 132.61 Mn |
| Dec 31, 2023 | -13.73 Mn |
| Sep 30, 2023 | 96.11 Mn |
| Jun 30, 2023 | 310.07 Mn |
| Mar 31, 2023 | -130.35 Mn |
| Dec 31, 2022 | 260.90 Mn |
| Sep 30, 2022 | 255.20 Mn |
| Jun 30, 2022 | 178.57 Mn |
| Mar 31, 2022 | 199.30 Mn |
| Dec 31, 2021 | 58.46 Mn |
| Sep 30, 2021 | 201.44 Mn |